Isparocto 2000 for intravenous injection contains Turoctocog Alpha Pegol, a recombinant Factor VIII therapy for hemophilia A. Developed by Novo Nordisk Pharma, this injectable (YJ code: 6343454D4024) is available as a 2,000 IU bottle with dissolving solution.
Isparocto 2000 for intravenous injection
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →